Wednesday, December 12, 2018

Agenda

Tuesday, October 09, 2018

08.30 - 09.00

Registration & Coffee

09.00 - 09.30

Welcome and Introductory Remarks

  • Andreas Xanthos*, Minister of Health
  • Εvangelos Filopoulos, President, Hellenic Cancer Society, Surgeon, Director of the Breast Cancer Clinic "Agios Savvas"
09.30 - 11.00 SESSION 1 | Cancer Policies and the Cost of Preventing, Researching and Treating Cancer
Chair
    Zenia Saridaki-Zoras, MD, PhD Medical Oncologist, Scientific Director of the Oncology Department “Asklepios”, Member of the Board of Directors of the Hellenic Society of Medical Oncology
Keynote Speaker

"The Role of the European Reference Networks"

    Luca Sangiorgi, MD, Head, Medical Genetic Department, Rizzoli Orthopedic Institute, Coordinator of Expert Centre Network, European Reference Network on Rare Bone Disorders

"The Necessity of Registries for Oncology in Greece"

    Ioannis Boukovinas, MD, PhD, Medical Oncologist, Head of Oncology Unit, “Bioclinic”, Thessaloniki, Greece, President of the Hellenic Society of Medical Oncology (HeSMO)

"Oncology: Global Trends, Local Challenges"

    Tomasz Kluszczynski, Senior Principal, IQVIA

"Propositions of Defining and Measuring Value in Cancer Care"

    Makis Papataxiarchis, President PhRMA Innovation Forum (PIF), Chairman, AMCHAM Pharma Committee

"Towards a National Cancer Strategy"

    Kathy Apostolidis, President - Hellenic Cancer Federation-ELL.O.K., Vice President of ECPC-European Cancer Patient Coalition

Discussion - Q&A

11.00 - 11.20

Coffee break

11.20 – 13.00 | Panel Discussion | Advancing Precision Medicine in Greece: Prerequisites, Opportunities and Challenges Going Forward
Chair
    Othon Iliopoulos, Associate Professor of Medicine, Harvard Medical School, Member of the Hellenic National Council of Research and Innovation (ΕΣΕΚ)
Welcome Speech
    Costas Fotakis, Alternate Minister for Research & Innovation, Ministry of Education
Keynote Speech

"Cancer Genotyping in the Clinic: 10 years of Sequencing at Massachusetts General Hospital"

    A. John Iafrate, MD, PhD, Medical Director, Center for Integrated Diagnostics, Associate in Pathology, Massachusetts General Hospital, Professor of Pathology, Harvard Medical School
Panelists
  • Dr Giorgos Chourdakis, Director, Research and Innovation Sector, Ministry of Education, Research and Religious Affairs
  • Petros Sfikakis, President of Medical School, University of Athens, Professor of Internal Medicine & Rheumatology, Medical School, National and Kapodistrian University of Athens
13.00 – 14.30 SESSION 2 | Innovation in Cancer Research & Treatment
Chair

Konstantinos N. Syrigos, MD, PhD, FCCP, Professor of Medicine & Medical Oncology, Head, 3rd Department of Medicine, Sotiria General Hospital, Athens School of Medicine, National & Kapodistrian University, Adj. Professor of Medicine, Pittsburgh School of Medicine, USA, Vis. Professor of Thoracic Oncology, Yale School of Medicine, USA

"HTA Appraisal of CAR-T Technology"

    Stephen Palmer, Professor, Deputy Director of TEEHTA, Centre for Health Economics, York University

"CAR-Ts and the Greek Healthcare System"

    George Galanopoulos, MD, Medical Director, Gilead Sciences Hellas

"The Evolution of Clinical Trials in Oncology"

    Christos Antonopoulos, MD, PhD, MBA, Director, Oncology Business Unit , AstraZeneca Pharmaceuticals Greece

"Welcoming the new generation treatment in Lung Cancer"

    Vasilis Ramfidis MD, MSc, Medical Oncologist, 3rd Department of Medicine Sotiria General Hospital, 251 General Air Force Hospital, Athens, Greece

Discussion - Q&A

14.30 - 15.15

Lunch Break

15.15 – 15.30

"Big Data & Personalized Medicine: Privacy Challenges in the GDPR era"

    Ioanna Michalopoulou, Lawyer, LL.M. Managing Partner at Michalopoulou & Associates Law Group
15.30 - 17.00 SESSION 3 | Personalized and Targeted Therapies & the Use of Biomarkers
Chair

Eleni Linardou, MD PhD, PhD Imperial College University of London, Medical Oncologist, Director - Oncology Unit, Metropolitan Hospital, Athens

"The Value of Personalized Medicine & Access Problems in the Greek Healthcare System"

    Maria Gazouli, PhD Associate Professor of Molecular Biology, Medical School, National & Kapodistrian University of Athens

"Access to Personalized Therapies with the Use of Biomarkers"

    Ioannis Mountzios, MSc, PhD, Medical Oncologist, 251 Airforce General Hospital, 2nd Oncology Department, Henry Dunant Hospital Center

"Liquid Biopsies and the Optimal Use of Biomarkers"

    George Pentheroudakis, MD Associate Professor of Oncology, Department of Medical Oncology, Medical School, University of Ioannina, Chair, ESMO Guidelines Committee

"Biomarker Tests, Quality Criteria and Accreditation of Diagnostic Laboratories"

    Christos Kroupis, Assistant Professor of Clinical Biochemistry and Molecular Diagnostics, Attikon University Hospital, National and Kapodistrian University of Athens, Lead Assessor in the National Accreditation System of Greece (E.SY.D.), National Representative, European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Discussion - Q&A

17.00

Concluding Remarks

*speaker to be confirmed

The agenda is under development.

  • ORGANIZED BY
  • UNDER THE AUSPICES OF
  • SPONSORS
  • SUPPORTERS
MSD
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • INTERPRETATION SPONSOR
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team